Business Context and Reporting Period
This Form 8-K was filed by Achieve Life Sciences, Inc. on January 24, 2020. The Company is incorporated in Delaware and its common stock (Ticker: ACHV) is listed on The NASDAQ Capital Market. The filing addresses a regulatory notice regarding the Company's compliance with continued listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing compliance issue rather than financial performance data.
Material Changes
On January 24, 2020, the Company received written notice from NASDAQ indicating non-compliance with the $1.00 minimum bid price requirement (Listing Rule 5550(a)(2)). This is a material event triggering a potential delisting process if not resolved.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has been granted an initial period of 180 calendar days (until July 22, 2020) to regain compliance.
- Requirement to Cure: To regain compliance, the closing bid price of the common stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days within the 180-day window.
- Extension Possibility: If the Company fails to comply by July 22, 2020, it may be afforded a second 180-day period, provided it meets the market value of publicly held shares and other initial listing standards (excluding the bid price).
- Remedial Actions: The Company may consider implementing a reverse stock split to cure the deficiency.
- Risks: There is no assurance the Company will regain compliance. Failure to do so within the allotted periods will result in delisting. The Company retains the right to appeal a delisting determination to a NASDAQ Listing Qualifications Panel.
Investor Verification Checklist
- Verify the current closing bid price of ACHV stock relative to the $1.00 threshold.
- Monitor for any announcements regarding a reverse stock split or other capital structure changes.
- Check the Company's market value of publicly held shares to assess eligibility for a potential second compliance period.
- Review future 8-K filings for updates on the compliance status or any appeal hearings.